Asthma

A Randomized, Double-Blind, Parallel Group, Multi-Center 24-Week Study Comparing the Efficacy and Safety of Three Doses of PT001 to Placebo and Open-label Spiriva® Respimat® in Subjects With Persistent Asthma.

Asthma

An 8-week, randomized, double-blind, placebo and active-controlled, parallel group, dose ranging study to evaluate the efficacy and safety of 3 doses of CHF 718 pMDI (beclometasone dipropionate) in asthmatic subjects.

Asthma

24-week study to further investigate the effect of benralizumab (30mg) on asthma exacerbations in patients with severe asthma.

Start typing and press Enter to search